Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-04

Clinical Trial Update: Melatonin Use for Sleep Problems in Alcohol Dependent Patients [Phase 2]

View source ↗

Summary

A completed Phase 2 clinical trial evaluated melatonin for sleep problems in patients with alcohol use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Alcohol-Related Disorders | Phase 2 | Status: COMPLETED